Co-Diagnostics, Inc. Additional Paid in Capital
Co-Diagnostics, Inc. (CODX) had Additional Paid in Capital of $124.02 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital $124.02M.
- 2026-03-31: Additional Paid in Capital $121.06M.
- 2025-12-31: Additional Paid in Capital $116.51M.
- 2025-09-30: Additional Paid in Capital $109.45M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $124.02M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $121.06M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $116.51M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $109.45M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $104.84M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $103.70M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $102.47M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $100.92M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $99.88M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $98.38M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $96.81M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $94.98M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $92.81M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $90.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $88.47M 10-K · filed 2024-03-14 | $88.47M 10-K · filed 2023-03-16 |
| 2022-09-30 | $86.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $83.84M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $81.80M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $80.27M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $53.46M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $52.04M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $50.82M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $49.16M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $48.04M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $46.73M 10-Q/A · filed 2020-11-03 | |
| 2020-03-31 | $45.17M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $26.69M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $26.47M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $26.20M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $25.61M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $17.62M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $16.26M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |